Microgravity as a Model for Studying Metabolic Disorders: Insights into Obesity, Insulin Resistance, and Liver and Pancreatic Conditions - Takeaways - MDSpire

Microgravity as a Model for Studying Metabolic Disorders: Insights into Obesity, Insulin Resistance, and Liver and Pancreatic Conditions

  • By

  • Mathew Vadukoot Lazar

  • Arun C. S. Menon

  • Rajesh Gopalakrishna

  • April 24, 2026

  • 0 min

Share

  • 1

    Microgravity and sedentary lifestyles lead to similar metabolic dysfunctions, including obesity, insulin resistance, and ectopic fat deposition.

  • 2

    Mechanical load deprivation alters fat distribution, promotes visceral adiposity, and initiates inflammation and immune-metabolic reprogramming.

  • 3

    Ground-based models like bed rest effectively mimic microgravity effects, providing insights into the physiological impacts of inactivity.

  • 4

    Emerging countermeasures, such as vibration platforms and resistive suits, are being explored to mitigate metabolic changes due to inactivity.

  • 5

    The review highlights microgravity as a valuable translational model for understanding and addressing lifestyle-induced metabolic disorders.

Original Source(s)

Microgravity as a Model for Studying Metabolic Disorders: Insights into Obesity, Insulin Resistance, and Liver and Pancreatic Conditions

  • by Mathew Vadukoot Lazar, Arun C. S. Menon, Rajesh Gopalakrishna

  • April 24, 2026

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?